Cargando…
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan
BACKGROUND: Dexamethasone, remdesivir, and baricitinib reduce mortality in patients with coronavirus disease 2019 (COVID-19). A single-arm study using combination therapy with all three drugs reported low mortality in patients with severe COVID-19. In this clinical setting, whether dexamethasone adm...
Autores principales: | Hirasawa, Yasutaka, Terada, Jiro, Shionoya, Yu, Fujikawa, Atsushi, Isaka, Yuri, Takeshita, Yuichiro, Kinouchi, Toru, Koshikawa, Ken, Tajima, Hiroshi, Kinoshita, Taku, Tada, Yuji, Tatsumi, Koichiro, Tsushima, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110979/ https://www.ncbi.nlm.nih.gov/pubmed/37119744 http://dx.doi.org/10.1016/j.resinv.2023.03.009 |
Ejemplares similares
-
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia
por: Isaka, Yuri, et al.
Publicado: (2022) -
High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index
por: Takeshita, Yuichiro, et al.
Publicado: (2022) -
Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients
por: Takeshita, Yuichiro, et al.
Publicado: (2021) -
Development of a novel score model to predict hyperinflammation in COVID-19 as a forecast of optimal steroid administration timing
por: Takeshita, Yuichiro, et al.
Publicado: (2022) -
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study
por: Takeshita, Yuichiro, et al.
Publicado: (2021)